Home
Home >> Medical Science>> Urology>> Tumors of the prostate

Tumors of the prostate MCQ Question with Answer

Tumors of the prostate MCQ with detailed explanation for interview, entrance and competitive exams. Explanation are given for understanding.

Download Tumors of the prostate MCQ Question Answer PDF

Question No : 50
Regarding radiotherapy for prostate cancer, what is the lowest recommended dose for salvage therapy?

54 Gy
64 Gy
74 Gy
84 Gy
View Answer   Discuss

Question No : 51
In descending order, the commonest complications of external beam radiation therapy for prostate cancer are:

urethral stricture, impotence, and rectal bleeding
impotence, rectal bleeding, and urethral stricture
impotence, urethral stricture, and rectal bleeding
rectal bleeding, impotence, and urethral stricture
View Answer   Discuss

Question No : 52
What is false regarding prostate adenocarcinoma in the peripheral zone?

85% of prostate adenocarcinomas are located in the peripheral zone
15% of them are multifocal
they tend to extend outside the prostate through the perineural space
the presence of perineural invasion does not worsen the prognosis
View Answer   Discuss

Question No : 53
Screening for prostate cancer is recommended for men who are:

at average risk, aging 50 yrs., and have at least a 10-year life expectancy
aging 40 yrs., and had a first-degree relative diagnosed with prostate cancer before age 65
aging 40 yrs., African Americans
all of the above
View Answer   Discuss

Question No : 54
BPH patients on finasteride longer than 6 months are expected to have:

decreased t-PSA but increased f-PSA
decreased t-PSA but unaltered f-PSA
decreased t-PSA and decreased f-PSA
any of the above
View Answer   Discuss

Question No : 55
What is false concerning TRUS prostatic biopsy?

a 12-core biopsy is the standard
in preparation for the procedure, a self-administered enema is suggested
sepsis might complicate the procedure
the biopsy path is best visualized in the coronal plane
View Answer   Discuss

Question No : 56
What is the major advantage of neoadjuvant androgen deprivation before radical prostatectomy on treating clinical stages (cT1-T2) prostate cancers?

reduces positive surgical margins
reduces local recurrence
has no proven advantage
reduces cardiac complications
View Answer   Discuss